Finoriq research workspace
Aclarion, Inc. (ACON) SEC Filings & Filing Highlights
Aclarion, Inc. operates as a healthcare technology company in the United States. Review ACON SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
- Company
- Aclarion, Inc. (ACON)
- Ticker
- ACON
- Market Cap
- $6.4M
- Latest Price
- $2.60
- Industry
- Medical Devices
Aclarion, Inc. (ACON) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Aclarion, Inc. (ACON).
| Event | Form | Date |
|---|---|---|
| On June 4, 2026, the Company held its 2026 Annual Meeting of StockholdersOn June 4, 2026, the Company held its 2026 Annual Meeting of Stockholders | 8-K5.07 | 2026-06-04 |
| Aclarion Announces $2.5 Million Stock Repurchase PlanAclarion Announces $2.5 Million Stock Repurchase Plan | 8-K8.01 | 2026-04-22 |
| Aclarion, Inc. Adopts Limited Duration Stockholder Rights PlanAclarion, Inc. Adopts Limited Duration Stockholder Rights Plan | 8-K8.01 | 2026-03-19 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-03-19 |
| Aclarion, Inc.: Security holder rights changeOn March 19, 2026, the board of directors (the “Board”) of Aclarion, Inc., a Delaware corporation (the “Company”), adopted a stockholder ri... | 8-K3.03 | 2026-03-19 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.